Abstract:OBJECTIVE:To explore the expression and clinical significance of chemokine CXCL10 and CXCR3 in hepatocellular carcinoma (HCC). METHODS:The expression and prognostic of CXCL10 and CXCR3 in HCC tumor tissues and non-tumor tissues were analyzed in two different publicly available databases the Cancer Genome Atlas (TCGA) and Liver Cancer Institute (LCI). In addition, quantitative real-time PCR (qPCR) was used to detect the mRNA expression of CXCL10 and CXCR3 in 45 HCC clinical samples with HBV infection background. Pearson correlation and Spearman rank correlation were used to determine the correlation between the expression level of CXCL10 and CXCR3 in tumor and non-tumor tissues. RESULTS:In TCGA database, the expression of CXCL10 in HCC tumor tissues was significantly higher than that in non-tumor tissues (nonpaired samples: 3.379±2.081 vs. 2.213±2.274, P<0.001; paired samples: 3.159±2.267 vs. 2.213±2.274, P=0.018). Similarly in LCI datebase (7.625±1.683 vs. 7.287±1.328, P=0.009). And higher CXCL10 expression was significantly associated with a better prognosis in the patients with HCC both in TCGA and LCI database (P=0.107, P=0.002). In TCGA database, the expression of CXCR3 in HCC tumor tissues was significantly higher than that in non-tumor tissues (nonpaired samples: -0.906±1.697 vs. -1.978±1.629, P<0.001; paired samples: -1.329±1.732 vs. -1.978±1.629, P=0.037), while lower in LCI database (3.989±0.339 vs. 4.074±0.309, P=0.003). In both databases, higher CXCR3 expression was significantly associated with a better prognosis in the HCC patients (P=0.004, P=0.014). Furthermore, in TCGA database, the expression level of CXCL10 and CXCR3 was positively correlated both in HCC tumor tissues and matched non-tumor tissues (r=0.584, P<0.001; r=0.776, P<0.001). The qPCR assay showed that the expression of CXCL10 in HBV-related HCC tumor tissues was significantly higher than those in normal liver tissues [0.479(0.223, 1.094) vs. 0.131(0.106, 0.159), P=0.010], and the expression in HBV-related non-tumor tissues was also significantly higher than those in normal liver tissues [0.484(0.241, 0.846) vs. 0.131(0.106, 0.159), P<0.001]. The same was true as CXCR3 [0.011(0.006, 0.019) vs. 0.002(0.001, 0.004), P=0.004; 0.016(0.011, 0.021) vs. 0.002(0.001, 0.004), P<0.001]. However there was no significant difference of CXCL10 and CXCR3 between tumor tissues and matched non-tumor tissues (P=1.000, P=0.374). CONCLUSION:Expression of CXCL10 was up-regulated in HCC tissues, expression of CXCR3 was down-regulated in HBV-related HCC tissues, and the higher expression of both genes was correlated with better overall survival in HCC patients.

Chemokine receptor CXCR4 expression in hepatocellular carcinoma patients increases the risk of bone metastases and poor survival

The Impact of Chemokine Receptor CXCR4 on Breast Cancer Prognosis: A Meta-Analysis

[Nuclear Accumulation of CXCR4 and Overexpressions of VEGF-C and CK19 Are Associated with a Higher Risk of Lymph Node Metastasis in Hepatocellular Carcinoma].

Increased Expression of Vascular Endothelial Growth Factor-C and Nuclear Cxcr4 in Hepatocellular Carcinoma is Correlated with Lymph Node Metastasis and Poor Outcome

The chemokine receptor CCR4 promotes tumor growth and lung metastasis in breast cancer

Transmembrane Receptor CXCR7 Increases the Risk of Extrahepatic Metastasis of Relatively Well-Differentiated Hepatocellular Carcinoma Through Upregulation of Osteopontin.

High CXC chemokine receptor 4 expression is an adverse prognostic factor in patients with clear-cell renal cell carcinoma

Role of chemokine receptor CXCR4/CXCL12 signaling pathway in hepatic metastasis of colorectal carcinoma

Expression of CXCR4 and Breast Cancer Prognosis: a Systematic Review and Meta-Analysis

High Expression of CXCR7 Combined with Alpha Fetoprotein in Hepatocellular Carcinoma Correlates with Extra-Hepatic Metastasis to Lung after Hepatectomy.

Role of Chemokine Receptor CXCR4 in Lung Metastasis of Human Hepatocellular Carcinoma

Reduced Expression of Chemokine Receptors on Peripheral Blood Lymphocytes in Patients with Hepatocellular Carcinoma.

Strong Expression of Chemokine Receptor CXCR4 by Renal Cell Carcinoma Cells Correlates with Metastasis

[Expression and clinical significance of chemokine CXCL10 and its receptor CXCR3 in hepatocellular carcinoma].

Use Of Cxcr4 Expression To Predict The Efficacy Of Sorafenib Treatment In Patients With Metastatic Renal Cell Carcinoma

High CXC chemokine receptor 1 level represents an independent negative prognosticator in non-metastatic clear-cell renal cell carcinoma patients.

CXCR3 from chemokine receptor family correlates with immune infiltration and predicts poor survival in osteosarcoma

CXCR4 overexpression in chronic lymphocytic leukemia associates with poorer prognosis: A prospective, single-center, observational study

Overexpression of CXCL5 Mediates Neutrophil Infiltration and Indicates Poor Prognosis for Hepatocellular Carcinoma.

Upregulated Expression of C-X-C Chemokine Receptor 4 is an Independent Prognostic Predictor for Patients with Gastric Cancer.

CXCR4/TGF-β1 mediated hepatic stellate cells differentiation into carcinoma-associated fibroblasts and promoted liver metastasis of colon cancer.